Bone induction in craniofacial defects

Orthodontics and Craniofacial Research

Volumn 8, Issue 4, 2005, Pages 259-266

  Nacamuli, R P ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Craniofacial defects; Tissue engineering and mesenchymal cells

Indexed keywords

BIOMIMETIC MATERIAL; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ADIPOSE TISSUE; ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BONE MARROW CELL; BONE REGENERATION; CRANIOFACIAL MALFORMATION; CRANIOTOMY; CYTOLOGY; DRUG EFFECT; HUMAN; METHODOLOGY; PLASTIC SURGERY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ADIPOSE TISSUE; ANIMALS; BIOMIMETIC MATERIALS; BONE MARROW CELLS; BONE REGENERATION; CRANIOFACIAL ABNORMALITIES; CRANIOTOMY; HUMANS; LACTIC ACID; MEMBRANES, ARTIFICIAL; POLYGLYCOLIC ACID; POLYMERS; RECONSTRUCTIVE SURGICAL PROCEDURES; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 33644674024     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1111/j.1601-6343.2005.00348.x     Document Type: Article

References (67)

1. Zias J, Pomeranz S. Serial craniectomies for intracranial infection. Int J Osteoarchaeol 1992;2:183-6.
2. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002;5:143-51.
3. Rah DK. Art of replacing craniofacial bone defects. Yonsei Med J 2000;41:756-65.
4. Marchac D. Split-rib grafts in craniofacial surgery. Plast Reconstr Surg 1982;69:566-7.
5. Bruens ML, Pieterman H, de Wijn JR, Vaandrager JM. Porous polymethylmethacrylate as bone substitute in the craniofacial area. J Craniofac Surg 2003;14:63-8.
6. Kline RM Jr, Wolfe SA. Complications associated with the harvesting of cranial bone grafts. Plast Reconstr Surg 1995;95:5-13.
7. Mulliken JB, Glowacki J, Kaban LB, Folkman J, Murray JE. Use of demineralized allogeneic bone implants for the correction of maxillocraniofacial deformities. Ann Surg 1981;194:366-72.
8. Moss SD, Joganic E, Manwaring KH, Beals SP. Transplanted demineralized bone graft in cranial reconstructive surgery. Pediatr Neurosurg 1995;23:199-204 (discussion 204-5).
9. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
10. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 1979;76:1828-32.
11. Maddox E, Zhan M, Mundy GR, Drohan WN, Burgess WH. Optimizing human demineralized bone matrix for clinical application. Tissue Eng 2000;6:441-8.
12. Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, Long MW. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 2000;18:954-8.
13. Bumgardner JD, Wiser R, Gerard PD, Bergin P, Chestnutt B, Marin M et al. Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym Ed 2003;14:423-38.
14. Saadeh PB, Khosla RK, Mehrara BJ, Steinbrech DS, McCormick SA, DeVore DP et al. Repair of a critical size defect in the rat mandible using allogenic type I collagen. J Craniofac Surg 2001;12:573-9.
15. Seol YJ, Lee JY, Park YJ, Lee YM, Ku Y, Rhyu IC et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 2004;26:1037-41.
16. Solchaga LA, Gao J, Dennis JE, Awadallah A, Lundberg M, Caplan AI et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002;8:333-47.
17. Cho BC, Kim JY, Lee JH, Chung HY, Park JW, Roh KH et al. The bone regenerative effect of chitosan microsphere-encapsulated growth hormone on bony consolidation in mandibular distraction osteogenesis in a dog model. J Craniofac Surg 2004;15:299- 311 (discussion 312-3).
18. Zahraoui C, Sharrock P. Influence of sterilization on injectable bone biomaterials. Bone 1999;25(2 Suppl.):63S-5S.
19. Lanza RP, Langer RS, Vacanti J. Principles of Tissue Engineering, 2nd edn. San Diego, CA: Academic Press; 2000.
20. Behravesh E, Yasko AW, Engel PS, Mikos AG. Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop 1999;367(Suppl.):S118-29.
21. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
22. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;28:1445-53.
23. Boyan BD, Lohmann CH, Somers A, Niederauer GG, Wozney JM, Dean DD et al. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999;46:51-9.
24. Stile RA, BurghardtWR, Healy KE. Synthesis and characterization of injectabe poly(n-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999;32:7370-9.
25. Stile RA, Healy KE. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules 2001;2:185-94.
26. Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999;17:615-23.
27. Albee FH. Studies in bone growth: triple CaP as a stimulus to osteogenesis. Ann Surg 1920;71:32-36.
28. LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop 2002;395:81-98.
29. Ducheyne P. Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res 1987;21(A2 Suppl.):219-36.
30. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996;17:175-85.
31. Chou Y-F, Huan W, Dunn JC, Miller T, Wu BM. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 2005;26:285-95.
32. Lemons JE. Ceramics: past, present, and future. Bone 1996;19(1 Suppl.):121S-8S.
33. Bahadur G. The moral status of the embryo: the human embryo in the UK Human Fertilisation and Embryology (Research Purposes) Regulation 2001 debate. Reprod Biomed Online 2003;7:12-6.
34. Chin JJ. Ethical issues in stem cell research. Med J Malaysia 2003;58(Suppl. A):111-8.
35. Weissman IL. Stem cells - scientific, medical, and political issues. N Engl J Med 2002;346:1576-9.
36. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-75.
37. Forbes SJ, Poulsom R, Wright NA. Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 2002;9:625-30.
38. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
39. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95.
40. Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 2004;10:33-41.
41. Endres M, Hutmacher DW, Salgado AJ, Kaps C, Ringe J, Reis RL et al. Osteogenic induction of human bone marrow-derived mesenchymal progenitor cells in novel synthetic polymerhydrogel matrices. Tissue Eng 2003;9:689-702.
42. Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA, Mikos AG. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A 2003;100:14683-8.
43. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994;161:218-28.
44. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1992;1:23-32.
45. Abukawa H, Terai H, Hannouche D, Vacanti JP, Kaban LB, Troulis MJ. Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg 2003;61:94-100.
46. Zuk PA. Stem cell research has only just begun. Science 2001;293:211-2.
47. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28.
48. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000;28:707-15.
49. Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996;11:568-77.
50. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-26.
51. Lee JA, Parrett BM, Conejero JA, Laser J, Chen J, Kogon AJ et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 2003;50:610-7.
52. Hicok KC, Du Laney TV, Zhou YS, Halvorsen YD, Hitt DC, Cooper LF et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10:371-80.
53. Dragoo JL, Choi JY, Lieberman JR, Huang J, Zuk PA, Zhang J et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 2003;21:622-9.
54. Cowan CM, Shi YY, Aalami OO, Chou YF, Mari C, Thomas R et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-7.
55. Xu HH, Quinn JB, Takagi S, Chow LC. Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 2004;25:1029-37.
56. Xu HH, Simon CG Jr. Self-hardening calcium phosphate composite scaffold for bone tissue engineering. J Orthop Res 2004;22:535-43.
57. Ramay HR, Zhang M. Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials 2004;25:5171-80.
58. Eppley BL, Stal S, Hollier L, Kumar M. Compartmentalized bone regeneration of cranial defects with biodegradable barriers - effects of calcium sodium phosphate surface coatings on Lacto- Sorb. J Craniofac Surg 2002;13:681-6.
59. Murphy WL, Simmons CA, Kaigler D, Mooney DJ. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 2004;83:204-10.
60. Bidic SM, Calvert JW, Marra K, Kumta P, Campbell P, Mitchell R et al. Rabbit calvarial wound healing by means of seeded Caprotite scaffolds. J Dent Res 2003;82:131-5.
61. Chou YF, Chiou WA, Xu Y, Dunn JC, Wu BM. The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials 2004;25:5323-31.
62. Eppley BL, Hollier L, Stal S. Hydroxyapatite cranioplasty: 2. Clinical experience with a new quick-setting material. J Craniofac Surg 2003;14:209-14.
63. Verheggen R, Merten HA. Correction of skull defects using hydroxyapatite cement (HAC) - evidence derived from animal experiments and clinical experience. Acta Neurochir (Wien) 2001;143:919-26.
64. Eppley BL, Sadove AM. Resorbable coupling fixation in craniosynostosis surgery: experimental and clinical applications. J Craniofac Surg 1995;6:477-82.
65. Tharanon W, Sinn DP, Hobar PC, Sklar FH, Salomon J. Surgical outcomes using bioabsorbable plating systems in pediatric craniofacial surgery. J Craniofac Surg 1998;9:441-4 (discussion 445-7).
66. Surpure SJ, Smith KS, Sullivan SM, Francel PC. The use of a resorbable plating system for treatment of craniosynostosis. J Oral Maxillofac Surg 2001;59:1271-5; discussion 1275-6.
67. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71:1241-57.